Clinical Trial Update: Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating the effects of Cyclodynon on reducing cumulative breast cancer risk in women aged 40-52 with Mammographic Breast Density.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mammographic Breast Density

Drugs mentioned

• Cyclodynon

Snippet

Sponsor: Dr. Struk Tetiana | Conditions: Mammographic Breast Density | Phase 4 | Status: UNKNOWN